drugset / Trial / NCT02850848
Pharmacokinetics of Two Formulations of Entecavir
Phase 4
Completed
39 enrolled
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of a Test Formulation of Entigin Film Coated Tablet 0.5mg (Entecavir 0.5 mg), Compared to an Equivalent Dose of a Reference Drug Product (Baraclude 0.5mg Tablets) in Healthy
Timeline
- Start
- 2015-12
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 0.5 mg | — |